| Document |
Document Title |
|
WO/2024/086100A1 |
Methods and formulations for the systemic protection of an animal from exposure to a photocarcinogen. The methods include orally administering to an animal a formulation comprising a therapeutically effective amount of one or more UV-abs...
|
|
WO/2024/084197A1 |
The invention relates to methods for reducing the level of xenobiotic in an environment by contacting the environment with a composition comprising one or more bacterial strains. The invention also relates to bacterial strains for use in...
|
|
WO/2024/085637A1 |
The present invention relates to a composition for preventing aging and use of the composition, the composition comprising GCLC, ENO1, Map1s, KNG1 and various combinations thereof, derived from plasma treated with Oct4, Sox2, Klf4, and c...
|
|
WO/2024/079471A1 |
A prebiotic oligosaccharide composition for use in reducing the level of ammonia. The composition comprises oligosaccharide compounds, for example galactooligosaccharide compounds, which includes: (a) at least 8 wt% Gal-(β1-3)-Gal-(β1-...
|
|
WO/2024/077488A1 |
Use of a polygonum capitatum granular preparation in the preparation of drugs for clearing heat and promoting diuresis, inducing diuresis for treating stranguria, treating urinary tract infection or stones, treating pyelonephritis, detox...
|
|
WO/2024/078124A1 |
Provided in the present invention is the use of a TDGF1 gene in the preparation of a drug for treating aging-related diseases or reversing cell aging. Compared with the prior art, the present invention has the following advantages: the u...
|
|
WO/2024/078483A1 |
The present invention belongs to the technical field of biological medicines. Disclosed is a novel ceramide which has a structure represented as formula I. Further disclosed in the present invention are a preparation method for and the u...
|
|
WO/2024/077310A1 |
A preparation comprising the YEL002 compound as an active ingredient for the prevention or treatment of one or more diseases or conditions, and methods of using such preparations. The preparations may be a sublingual pill, an injection, ...
|
|
WO/2024/067604A1 |
The present invention provides a use of salvianolic acid A (SAA), as a raw material of a novel anti-aging drug, in cellular senescence therapy, tumor therapy, and life extension. According to the present invention, it is found that SAA c...
|
|
WO/2024/065907A1 |
Provided are a pentacyclic triterpene saponin derivative, a preparation method therefor, and a use thereof. A compound A3 is used as a raw material, a derivative is prepared by targeting a carboxyl group of C-28 and using an esterificati...
|
|
WO/2024/071404A1 |
The present invention addresses the problem of providing a food-applicable antioxidant peptide and an antioxidant composition containing same. The present invention provides a peptide comprising the amino acid sequence of Gln-Pro-Glu-Val...
|
|
WO/2024/055795A1 |
Disclosed herein are a medicine and food dual-purpose composition capable of resisting blue light damage to retina, a preparation method therefor, and use thereof, and belongs to the technical field of medicine and food dual purposes. Th...
|
|
WO/2024/059829A1 |
Provided are compositions and methods for protecting tissue of patients undergoing radiation therapy from off-target radiation damage. The compositions comprise a compound selected from the group consisting of: glipizide, etidronate, mer...
|
|
WO/2024/054394A1 |
Compositions and methods for treating oxidative stress, and conditions where oxidative stress contributes to conditions such as diabetes, in a subject by administering an effective amount of cobinamide. Oxidative stress can be caused by,...
|
|
WO/2024/045344A1 |
Provided is a preparation method for a cyanide antidote injection, which comprises a preparation method for a sodium nitrite injection, and a preparation method and a filling method for a sodium thiosulfate injection. The sodium nitrite ...
|
|
WO/2024/048161A1 |
The purpose of the present invention is to provide a novel component for ameliorating biological symptoms such as sagging of the skin. An antioxidant according to the present invention is characterized by containing dragon fruit-derive...
|
|
WO/2024/041604A1 |
The present invention belongs to the fields of biotechnology and biopharmaceutical technology. Disclosed is use of a yogurt-derived polypeptide in the preparation of a drug for delaying telomere shortening and an anti-aging drug. The pre...
|
|
WO/2024/037484A1 |
The present invention relates to the technical field of biopharmaceutical preparation, and in particular to a nicotinamide mononucleotide composite and a preparation method therefor. Nicotinamide mononucleotide (NMN) has been shown to be...
|
|
WO/2024/037138A1 |
The present invention relates to the field of pharmaceutic preparations, and in particular, to a phloretin-isoniazid cocrystal and a preparation method therefor. The phloretin-isoniazid cocrystal of the present invention is a cocrystal o...
|
|
WO/2024/038980A1 |
The present invention relates to Lactobacillus plantarum KU15120 strain and a use thereof. The (Lactobacillus plantarum KU15120 strain was found to have antioxidative and anti-obese effects, which led to the present invention.
|
|
WO/2024/039331A1 |
The present invention belongs to bone tissue engineering technical field, relates to a bio-compliant product which is suitable for use in repair and/or treatment of bone breakages and/or bone diseases that are genetic or that occur after...
|
|
WO/2024/038137A1 |
The present disclosure relates to a functionalized polymer, for use in treating a disease correlated with heavy metal-induced toxicity or heavy metal-induced carcinogenicity in a subject in need thereof, wherein said functionalized polym...
|
|
WO/2024/033786A1 |
Methods for the purification of impure triethylenetetramine into highly pure triethylenetetramine are described. In particular, methods for the preparation of relatively pure salts of triethylenetetramine starting from crude triethylenet...
|
|
WO/2024/032710A1 |
A method against snake envenomation includes administering to a subject in need thereof a pharmaceutical composition containing a flavonoid compound. The flavonoid compound is selected from the group consisting of isorhamnetin, quercetin...
|
|
WO/2024/034322A1 |
[Problem] The purpose of the present invention is to provide an enhancing agent having a useful action such as an enhancement action on a cardiolipin molecular species that is a mitochondrial inner membrane component having 3,5-dihydroxy...
|
|
WO/2024/031997A1 |
The present invention relates to N-N-bis-oxazolidinone alkaloid compounds, a preparation method and a use in the medical field. The present invention provides two new N-N-bis-oxazolidinone alkaloid isomers isolated and purified from Loni...
|
|
WO/2024/029904A1 |
Disclosed herein are an antioxidant composition for cells, comprising hyaluronan and proteoglycan link protein 1 (HAPLN1) or the gene encoding same as an active ingredient, and a method for antioxidation in cells using the composition. A...
|
|
WO/2024/024923A1 |
The present invention addresses the problem of providing a medicine that promotes DNA damage caused by radiation in malignant tumor (cancer) cells while suppressing DNA damage caused by radiation in normal cells. The present invention pr...
|
|
WO/2024/025962A1 |
The present disclosure relates to treating tumor tissue using magneto-immunotherapy (Mag-IT) techniques. For example, a method may include administering a magnetotherapy treatment to tumor tissue of a subject and administering an immune ...
|
|
WO/2024/020696A1 |
The present application includes an enantiomerically pure compound of Formula (R)-I or a salt and/or solvate thereof (R)-I. Also included are compositions of the enantiomerically pure compound of Formula (R)-I as well as methods of using...
|
|
WO/2024/023192A1 |
The present invention generally relates to the field of skin care. More particularly, the invention relates to a cosmetic or therapeutic skin care composition comprising at least one skin-health promoting Staphylococcus strain that exert...
|
|
WO/2024/023550A1 |
The invention entitled "Malt supplement Containing Oleocanthal, with Anti- inflammatory, Antioxidant and Anti-cancer Properties" is in the field of extracting and formulating a compound used in food, pharmaceutical, and supplement indust...
|
|
WO/2024/026042A1 |
Described herein are compositions and methods for treating lung damage associated with cancer therapy, for example radiation-induced lung damage or chemotherapy-induced lung damage. Lung damage may be treated by administering heparin, op...
|
|
WO/2024/022778A1 |
The present invention relates to a combination product comprising, as active substances, at least vitamin A, B1, B2, B3, B5, B6, B8, B9, B12, C, D, E, selenium, zinc, molybdenum, iron, manganese, magnesium, calcium, copper, lutein, Siber...
|
|
WO/2024/023190A1 |
The present invention generally relates to the field of skin care. More particularly, the invention relates to a cosmetic or therapeutic skin care composition comprising at least one of the skin-health promoting Staphylococcus strains se...
|
|
WO/2024/017331A1 |
The present invention belongs to the fields of bioengineering and biological treatment. Disclosed are an anti-ADM monoclonal antibody or a fragment thereof and a pharmaceutical composition, a detection reagent, or a kit comprising the mo...
|
|
WO/2024/018955A1 |
The present invention addresses the problem of providing an oral composition which contains ergothioneine or a salt thereof and a glucosamine compound and yet in which the bitterness derived from ergothioneine or the salt thereof and the...
|
|
WO/2024/016935A1 |
The present invention belongs to the field of functional emulsions. Disclosed is a method for improving the embedding rates of ginsenosides Rg3 and CK and the stability of a nanoemulsion. The method for improving the embedding rates of r...
|
|
WO/2024/008187A1 |
A prunus lannesiana extract is obtained by using a solvent to extract dried prunus lannesiana, the weight ratio of the solvent to prunus lannesiana being (20-40):1. The prunus lannesiana extract can be used for preparing a composition fo...
|
|
WO/2024/011230A1 |
The present invention relates in general to compositions and methods for treating an animal or human patient in need of treatment for ophthalmic diseases or conditions involving oxidative stress and treatment with an ophthalmic implant c...
|
|
WO/2024/007901A1 |
Provided is a method for preparing oxyresveratrol, comprising the steps of: (S1) providing a raw material containing mulberroside A; and (S2) using β-glucanase to perform enzymatic hydrolysis treatment on the raw material containing mul...
|
|
WO/2024/010353A1 |
The present invention relates to a pharmaceutical composition for preventing or treating inflammatory diseases comprising a compound of chemical formula 1, and to a cosmetic composition comprising the compound. By comprising the compound...
|
|
WO/2024/010473A1 |
The object of the invention is a nitroxyl polyphenol derivative of formula (i) wherein Q is a group derived from a polyphenol; L is an ester linking group containing 1 to 3 carbon atoms; A is a 5- or 6-membered heterocyclic group contain...
|
|
WO/2024/009990A1 |
The present invention addresses the problem of providing a novel radiation damage protection agent. The present invention provides a radiation damage protection agent that contains an adipose tissue or an adipose tissue-derived product [...
|
|
WO/2024/007726A1 |
The present invention relates to a small-molecule compound, and the use thereof as a cosmetic active ingredient and a preparation method therefor. The small-molecule compound is a compound as shown in the following general formula (I). R...
|
|
WO/2024/011127A1 |
Provided herein are RNA-enriched compositions that can be used to treat age-related disorders. Also provided herein are methods for producing a such compositions.
|
|
WO/2024/010866A1 |
Disclosed herein include methods, compositions, and kits suitable for use in reducing or preventing oxidative stress and/or reductive stress. In some embodiments, the method comprises contacting a redox-sensitive composition with an effe...
|
|
WO/2024/005156A1 |
The present invention addresses the problem of providing a novel nucleic acid drug capable of simultaneously achieving both a high gene regulatory effect and a low toxicity. Provided is a toxicity reducing agent for a nucleic acid drug...
|
|
WO/2024/006568A1 |
The present disclosure is directed to salt forms of ʟ-Ergothioneine and crystalline forms thereof, and processes for their preparation. Also provided is a crystalline form of ʟ‑Ergothioneine (Form C) and a crystalline form of DL-Ergo...
|
|
WO/2024/001738A1 |
Provided are a water-soluble cannabidiol microcapsule and a method for preparing same. The method comprises the following steps of: adding a galactose to an aqueous solution of whey protein isolate, regulating the pH value, reacting, and...
|
